Ultromics
The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac conditions and new distribution channels.
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
EchoGo Heart Failure, developed in partnership with the Mayo Clinic, helps physicians detect heart failure with preserved ejection fraction.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
Ultromics’ EchoGo Core and EchoGo Pro platforms use AI-enabled echocardiograms to help physicians access heart function.
The joint UK-US scientific research team will use AI and machine learning to predict and detect heart failure.
The round was led by Oxford Sciences Innovation with participation from Mayo Clinic.
Mindwave Ventures unveils plans to open office in Leeds, appoints chief innovation and operating of…
Leeds, one of the largest cities in the UK, is said to be the home of over 250 health tech businesses.
EchoGo helps earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes.